Antithrombotiques et MTEV
11 essaisOCEANIC-STROKE2026Factor XIa Inhibition with Asundexian in Acute Non-Cardioembolic Stroke or High-Risk TIAANNEXA-I2024Andexanet Alfa for Acute Intracerebral Hemorrhage in Patients Receiving a Factor Xa InhibitorCARAVAGGIO2020Apixaban for the Treatment of Venous Thromboembolism Associated with CancerAUGUSTUS2019Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial FibrillationCOMPASS2017Cardiovascular Outcomes for People Using Anticoagulation StrategiesPEITHO2014Pulmonary Embolism Thrombolysis trialULTIMA2014Ultrasound Accelerated Thrombolysis of Pulmonary EmbolismWOEST2013What is the Optimal antiplatelet and anticoagulant therapy in patients with OAC and coronary StenTingAMPLIFY2013Apixaban for the Initial Management of Pulmonary Embolism and Deep-Vein ThrombosisHOKUSAI-VTE2013Edoxaban versus Warfarin for the Treatment of Symptomatic Venous ThromboembolismEINSTEIN-PE2012Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism